SM Entertainment announced on Wednesday, April 26, that it has acquired Studio CLON, a local post-production company. The entertainment firm made the acquisition through its subsidiary, Studio Kwangya, which specializes in the production of content for the firm’s metaverse businesses.
As per Yonhap News Agency, SM Entertainment bought a 51% stake in Studio CLON, but the financial details of the deal were not disclosed. This is a strategic move for the company, as the purchase was made with the aim of strengthening its metaverse ventures and content capabilities. With the deal, Studio CLON is now officially one of the Kpop powerhouse’s new subsidiaries.
The post-production company was founded in 2011, and since then, it has been providing a complete line of post-production services such as video editing and mixing of various content. It is said to be working on about 2,300 projects per year.
"We acquired the studio to reinforce our metaverse and content capabilities, one of the key sectors among the five main themes announced as part of our 'SM 3.0' business strategies in February," SM Entertainment said in a press release. "The acquisition demonstrates how we're pushing for the 3.0 strategies with speed."
Korea Joongang Daily further reported that SM Entertainment’s Studio Kwangya and Studio CLON would work together on the creation of high-quality metaverse content for virtual reality and related to virtual humans. They will also cooperate for the digital archiving of artist-related intellectual properties or IP.
Studio Kwangya was established by SME in July 2022, and it mainly works on visual effects projects, VR, and post-production. It has been creating metaverse-related content as well.
Finally, the purchase of Studio CLON is part of the entertainment firm’s “SM 3.0” that was unveiled in February.


FxWirePro- Major Crypto levels and bias summary
FxWirePro- Major Crypto levels and bias summary
Stellantis CEO Antonio Filosa to Reveal Turnaround Strategy Focused on U.S. Sales and China Partnerships
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations
Goldman Sachs to Pay $500M in 1MDB Shareholder Fraud Settlement
H.B. Fuller Eyes Advanced Medical Solutions in Potential £600M Takeover Deal
Why the Middle East is being left behind by global climate finance plans
Mexico's Undervalued Equity Market Offers Long-Term Investment Potential
Insignia Financial Shares Hit 3-Year High Amid Bain and CC Capital Bidding War
KiwiSaver shakeup: private asset investment has risks that could outweigh the rewards
Infosys Shares Drop Amid Earnings Quality Concerns
Apple Downgraded by Jefferies Amid Weak iPhone Sales and AI Concerns
UK Markets Face Rising Volatility as Hedge Funds Target Pound and Gilts
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors




